Abstract
In addition to neuronal vacuolation and astrocytic hypertrophy, dendritic atrophy is a prominent feature of prion disease. Because increased Notch-1 expression and cleavage releasing its intracellular domain (NICD) inhibit both dendrite growth and maturation, we measured their levels in brains from mice inoculated with Rocky Mountain Laboratory (RML) prions. The level of NICD was elevated in the neocortex, whereas the level of β-catenin, which stimulates dendritic growth, was unchanged. During the incubation period, levels of the disease-causing prion protein isoform, PrP Sc , and NICD increased concomitantly in the neocortex. Additionally, increased levels of Notch-1 mRNA and translocation of NICD to the nucleus correlated well with regressive dendritic changes. In scrapie-infected neuroblastoma (ScN2a) cells, the level of NICD was elevated compared with uninfected control (N2a) cells. Long neurofilament protein-containing processes extended from the surface of N2a cells, whereas ScN2a cells had substantially shorter processes. Transfection of ScN2a cells with a Notch-1 small interfering RNA decreased Notch-1 mRNA levels, diminished NICD concentrations, and rescued the long process phenotype. These results suggest that PrP Sc in neurons and in ScN2a cells activates Notch-1 cleavage, resulting in atrophy of dendrites in the CNS and shrinkage of processes on the surface of cultured cells. Whether diminishing Notch-1 activation in vivo can prevent or even reverse neurodegeneration in prion disease remains to be established.
References
35
Referenced
70
10.1016/S0092-8674(00)81163-0
10.1126/science.7909169
10.1212/WNL.37.8.1271
10.1212/WNL.41.9.1482
10.1101/gad.6.7.1213
10.1093/jnen/63.8.882
10.1126/science.7909170
10.1073/pnas.0402427101
10.1006/jmbi.1999.3386
10.1126/science.1100195
10.1016/S0092-8674(01)00440-8
10.1046/j.1365-2990.2000.00216.x
10.1073/pnas.94.25.13452
10.1073/pnas.052703499
10.1073/pnas.0402254101
10.1128/jvi.68.12.7859-7868.1994
10.1126/science.274.5295.2079
10.1038/2654
10.1110/ps.39201
10.1016/0304-3940(89)90298-X
10.1016/S0896-6273(00)80424-9
10.1038/nn1132
10.1016/S0306-4522(99)00157-8
10.1101/gad.1246005
10.1038/71104
10.1126/science.286.5440.741
10.1038/nbt748
10.1128/JVI.78.4.2088-2099.2004
10.1523/JNEUROSCI.23-02-00659.2003
10.1097/00005072-198707000-00005
10.1073/pnas.93.25.14945
10.1074/jbc.M308480200
10.1097/00005072-199808000-00003
- Sestan N. & Rakic P. (2002) in Notch from Neurodevelopment to Neurodegeneration: Keeping the Fate eds. Israel A. De Strooper B. Checler F. & Christen Y. (Springer Berlin) pp. 19-40.
- Scheibel A. B. (1979) in Congenital and Acquired Cognitive Disorders ed. Katzman R. (Raven New York) pp. 107-124.
Dates
Type | When |
---|---|
Created | 20 years, 7 months ago (Jan. 7, 2005, 8:46 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 2:03 p.m.) |
Indexed | 1 year, 2 months ago (June 30, 2024, 1:12 p.m.) |
Issued | 20 years, 7 months ago (Jan. 7, 2005) |
Published | 20 years, 7 months ago (Jan. 7, 2005) |
Published Online | 20 years, 7 months ago (Jan. 7, 2005) |
Published Print | 20 years, 7 months ago (Jan. 18, 2005) |
@article{Ishikura_2005, title={Notch-1 activation and dendritic atrophy in prion disease}, volume={102}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0408612101}, DOI={10.1073/pnas.0408612101}, number={3}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Ishikura, Nako and Clever, Jared L. and Bouzamondo-Bernstein, Essia and Samayoa, Erik and Prusiner, Stanley B. and Huang, Eric J. and DeArmond, Stephen J.}, year={2005}, month=jan, pages={886–891} }